19 research outputs found
Tiotropium improves FEV1 in patients with COPD irrespective of smoking status
This study evaluated whether the effect of tiotropium on the change in trough forced expiratory volume in 1s (FEV1), vs. placebo, is affected by smoking status. In a 3-month, double-blind study in 31 centres in Portugal, 311 (289 completed) patients were randomised to tiotropium 18 microg once daily or placebo. Baseline mean (standard deviation (SD)) FEV1 was 1.11 (0.39) l in the tiotropium group and 1.13 (0.39) l in the placebo group. Patients had an average smoking history of 55 (25.7) pack-years; 80 (26%) were smokers and 224 (74%) were ex-smokers. The primary end-point was change in morning pre-dose (i.e. trough) FEV1 after 12 weeks. Trough FEV1 at 12 weeks was significantly improved with tiotropium vs. placebo: the difference in means was 102 ml, P=0.0011, 95% confidence interval (CI) (41, 164). The difference in means in smokers was 138 ml, P=0.0105, CI (32, 244); in ex-smokers it was 66 ml, P=0.0375, CI (3, 129). The difference between smokers and ex-smokers was not statistically significant (P=0.6982) and may be due to greater variability and differences in disease severity. The significant improvement in lung function in patients treated with tiotropium vs. placebo in both smokers and ex-smokers suggests that tiotropium is an effective and well-tolerated therapy in chronic obstructive pulmonary disease (COPD), regardless of smoking status
Tiotropium improves FEV1 in patients with COPD irrespective of smoking status
This study evaluated whether the effect of tiotropium on the change in trough forced expiratory volume in 1s (FEV1), vs. placebo, is affected by smoking status. In a 3-month, double-blind study in 31 centres in Portugal, 311 (289 completed) patients were randomised to tiotropium 18 microg once daily or placebo. Baseline mean (standard deviation (SD)) FEV1 was 1.11 (0.39) l in the tiotropium group and 1.13 (0.39) l in the placebo group. Patients had an average smoking history of 55 (25.7) pack-years; 80 (26%) were smokers and 224 (74%) were ex-smokers. The primary end-point was change in morning pre-dose (i.e. trough) FEV1 after 12 weeks. Trough FEV1 at 12 weeks was significantly improved with tiotropium vs. placebo: the difference in means was 102 ml, P=0.0011, 95% confidence interval (CI) (41, 164). The difference in means in smokers was 138 ml, P=0.0105, CI (32, 244); in ex-smokers it was 66 ml, P=0.0375, CI (3, 129). The difference between smokers and ex-smokers was not statistically significant (P=0.6982) and may be due to greater variability and differences in disease severity. The significant improvement in lung function in patients treated with tiotropium vs. placebo in both smokers and ex-smokers suggests that tiotropium is an effective and well-tolerated therapy in chronic obstructive pulmonary disease (COPD), regardless of smoking status
Novel HIV-1 Knockdown Targets Identified by an Enriched Kinases/Phosphatases shRNA Library Using a Long-Term Iterative Screen in Jurkat T-Cells
HIV-1 is a complex retrovirus that uses host machinery to promote its replication. Understanding cellular proteins involved in the multistep process of HIV-1 infection may result in the discovery of more adapted and effective therapeutic targets. Kinases and phosphatases are a druggable class of proteins critically involved in regulation of signal pathways of eukaryotic cells. Here, we focused on the discovery of kinases and phosphatases that are essential for HIV-1 replication but dispensable for cell viability. We performed an iterative screen in Jurkat T-cells with a short-hairpin-RNA (shRNA) library highly enriched for human kinases and phosphatases. We identified 14 new proteins essential for HIV-1 replication that do not affect cell viability. These proteins are described to be involved in MAPK, JNK and ERK pathways, vesicular traffic and DNA repair. Moreover, we show that the proteins under study are important in an early step of HIV-1 infection before viral integration, whereas some of them affect viral transcription/translation. This study brings new insights for the complex interplay of HIV-1/host cell and opens new possibilities for antiviral strategies
Controle quÃmico da mancha-bacteriana do tomate para processamento industrial em campo
A smart pipe energy harvester excited by fluid flow and base excitation
This paper presents an electromechanical dynamic modelling of the partially smart pipe structure subject to the vibration responses from fluid flow and input base excitation for generating the electrical energy. We believe that this work shows the first attempt to formulate a unified analytical approach of flow-induced vibrational smart pipe energy harvester in application to the smart sensor-based structural health monitoring systems including those to detect flutter instability. The arbitrary topology of the thin electrode segments located at the surface of the circumference region of the smart pipe has been used so that the electric charge cancellation can be avoided. The analytical techniques of the smart pipe conveying fluid with discontinuous piezoelectric segments and proof mass offset, connected with the standard AC–DC circuit interface, have been developed using the extended charge-type Hamiltonian mechanics. The coupled field equations reduced from the Ritz method-based weak form analytical approach have been further developed to formulate the orthonormalised dynamic equations. The reduced equations show combinations of the mechanical system of the elastic pipe and fluid flow, electromechanical system of the piezoelectric component, and electrical system of the circuit interface. The electromechanical multi-mode frequency and time signal waveform response equations have also been formulated to demonstrate the power harvesting behaviours. Initially, the optimal power output due to optimal load resistance without the fluid effect is discussed to compare with previous studies. For potential application, further parametric analytical studies of varying partially piezoelectric pipe segments have been explored to analyse the dynamic stability/instability of the smart pipe energy harvester due to the effect of fluid and input base excitation. Further proof between case studies also includes the effect of variable flow velocity for optimal power output, 3-D frequency response, the dynamic evolution of the smart pipe system based on the absolute velocity-time waveform signals, and DC power output-time waveform signals